We are monitoring the impact of COVID-19 on APAC Glucose Monitoring Device Market Get in touch with us for detailed analysis Know More
Pulished Date February, 2020
ID: 570
Share on
Share on

Asia Pacific Glucose Monitoring Device Market Research Report – Segmented By Device Type, Application & Country (India, China, Japan, South Korea, Australia, New Zealand, Thailand, Malaysia, Vietnam, Philippines, Indonesia, Singapore, and Rest of APAC) - Industry Analysis, Size, Share, Trends and Growth Forecast (2020 to 2025)

Pulished: February, 2020
ID: 570
Pages: 140

APAC Glucose Monitoring Device Market Size (2020 to 2025)

The glucose monitoring device market in the Asia Pacific is expected to reach USD 0.5 billion by 2025 from USD 0.35 billion in 2020, at a CAGR of 7.42% from 2020 to 2025. The Asia Pacific market is more attention-grabbing as it is at a growing stage and is estimated to lead the market in the future due to the large patient pool in this region.

Glucose monitoring devices are used to detect the sugar level in our blood and are of several kinds, including a glucose meter, testing strips, and lancets. The usage of these devices consumes less time than glucose testing by customary methods in laboratories. These devices can be controlled easily as they are portable so convenient to carry. They offer the facility of monitoring glucose levels in our blood as it tests quantitatively. The glucose monitoring strip devices lead the market with maximum share and also has the highest growth rate.

The increasing prevalence of diabetes cases is due to an unhealthy lifestyle, low diet, excess alcohol consumption, and lack of physical activity. The growing baby boomer population, increasing incidence of an unhealthy lifestyle, and food habits are resulting in considerable differences in health are expected to expand the market growth during the forecast period.

However, this market faces inevitable loss due to some manufacturing defect or error in results. Besides, the accessibility of Continuous Glucose Monitors (CGM) also hinders the growth of the market.

This research report on the Asia Pacific Glucose Monitoring Device Market has been segmented and sub-segmented into the following categories:

  • By Device Type: Continuous Wearable Devices and Self-Monitoring Devices
  • By Application: Hospitals, Clinics & Diagnostic Centres, Home Setting, and Ambulatory Settings
  • By Country: India, China, Japan, South Korea, Australia, New Zealand, Thailand, Malaysia, Vietnam, Philippines, Indonesia, Singapore, and Rest of APAC

Regionally, the Asia Pacific market is the quickest growing region in the global market due to the existence of briskly enhancing healthcare technology, enormous patient pool, and increasing healthcare expenditure. China and India are the major contributing countries towards the market over the forecast period. 

China is dominating the APAC region during the analysis period because of its well-progressed technology, an increasing number of diabetes patients, a considerable amount spent on healthcare, and mounting support from the government towards the R&D. Around 1.2 million people with type-1 diabetes and 0.1 billion people are diagnosed with type-2 diabetes in China.

The Indian market is the second-largest leading market in the APAC. Growing necessity for blood glucose monitoring devices, funds, and investments for research, early identification of diabetes propels the market growth. 

A list of key companies profiled in this APAC Monitoring Device Market profiled in this report are Roche Diagnostics, LifeScan, Bayer Health care, Abbott Diabetes care Inc., AgaMatrix Inc., Arkray Inc., Medtronic, DexCom Inc., Nova Biomedical Corporation, and Terumo Europe NV.

1. Introduction                                 

                1.1 Market Definition                    

                1.2 Study Deliverables                  

                1.3 Base Currency, Base Year and Forecast Periods                          

                1.4 General Study Assumptions                

2. Research Methodology                                           

                2.1 Introduction                               

                2.2 Research Phases                      

                                2.2.1 Secondary Research           

                                2.2.2 Primary Research 

                                2.2.3 Econometric Modelling      

                                2.2.4 Expert Validation  

                2.3 Analysis Design                         

                2.4 Study Timeline                          

3. Overview                                       

                3.1 Executive Summary                

                3.2 Key Inferences                         

                3.3 New Developments                               

4. Drivers, Restraints, Opportunities, and Challenges Analysis (DROC)                                    

                4.1 Market Drivers                          

                4.2 Market Restraints                    

                4.3 Key Challenges                         

                4.4 Current Opportunities in the Market                              

5. Market Segmentation                                              

                5.1 By Device Type                         

                                5.1.1 Continuous Wearable Devices        

                                                5.1.1.1 Sensors

                                                5.1.1.2 Transmitters and Activators

                                5.1.2 Self-Monitoring Devices    

                                                5.1.2.1 Blood Glucose Meters

                                                5.1.2.2 Blood Glucose Strips

                                                5.1.2.3 Lancets

                                                5.1.2.4 Haemoglobin A1C testing Kits

                5.2 By Application                           

                                5.2.1 Hospitals  

                                5.2.2 Clinics and Diagnostic Centers         

                                5.2.3 Home Setting         

                                5.2.4 Ambulatory Settings           

6. Geographical Analysis                                              

                6.3 Asia-Pacific                 

                                6.1 Introduction               

                                6.2 China             

                                6.3 India              

                                6.4 Japan            

                                6.5 South Korea               

                                6.6 Australia      

7. Strategic Analysis                                       

                7.1 PESTLE analysis                         

                                7.1.1 Political     

                                7.1.2 Economic 

                                7.1.3 Social         

                                7.1.4 Technological         

                                7.1.5 Legal          

                                7.1.6 Environmental       

                7.2 Porter’s Five analysis                              

                                7.2.1 Bargaining Power of Suppliers        

                                7.2.2 Bargaining Power of Consumers    

                                7.2.3 Threat of New Entrants     

                                7.2.4 Threat of Substitute Products and Services              

                                7.2.5 Competitive Rivalry within the Industry     

8. Market Leaders' Analysis                                        

                8.1 Roche Diagnostics                    

                                8.1.1 Overview 

                                8.1.2 Product Analysis   

                                8.1.3 Strategic Evaluation and Operations            

                                8.1.4 Financial analysis  

                                8.1.5 Legal issues             

                                8.1.6 Recent Developments       

                                8.1.7 SWOT analysis       

                                8.1.8 Analyst View          

                8.2 LifeScan                       

                8.3 Bayer Health care                    

                8.4 Abbott Diabetes care Inc                      

                8.5 AgaMatrix Inc                            

                8.6 Arkray Inc                    

                8.7 Medtronic                   

                8.8 DexCom Inc                

                8.9 Nova Biomedical Corporation                             

                8.10 Teruma Europe NV                               

9. Competitive Landscape                                           

                9.1 Market share analysis                            

                9.2 Merger and Acquisition Analysis                       

                9.3 Agreements, collaborations and Joint Ventures                         

                9.4 New Product Launches                         

10. Expert Opinions                                        

                10.1 Market Outlook                     

                10.2 Investment Opportunities                 

Appendix                                           

                a) List of Tables                

                b) List of Figures

  • Regional and country-level analysis and forecasts of the study market; providing Insights on the major countries/regions in which this industry is blooming and to also identify the regions that are still untapped
  • Segment-level analysis in terms of technology, component, and type along with market size forecasts and estimations to detect key areas of industry growth in detail
  • Identification of key drivers, restraints, opportunities, and challenges (DROC) in the market and their impact on shifting market dynamics
  • Study of the effect of exogenous and endogenous factors that affect the global market; which includes broadly demographic, economics, and political, among other macro-environmental factors presented in an extensive PESTLE Analysis
  • Study the micro environment factors that determine the overall profitability of an Industry, using Porter’s five forces analysis for analysing the level of competition and business strategy development
  • A comprehensive list of key market players along with their product portfolio, current strategic interests, key financial information, legal issues, SWOT analysis and analyst overview to study and sustain the market environment
  • Competitive landscape analysis listing out the mergers, acquisitions, collaborations in the field along with new product launches, comparative financial studies and recent developments in the market by the major companies
  • An executive summary, abridging the entire report in such a way that decision-making personnel can rapidly become acquainted with background information, concise analysis and main conclusions
  • Expertly devised analyst overview along with Investment opportunities to provide both individuals and organizations a strong financial foothold in the market
  1. Asia-Pacific Glucose Monitoring Devices Market, By Region, From 2020 to 2025 (USD Million)
  2. Asia-Pacific Glucose Monitoring Devices Market, By Device Type, From 2020 to 2025 (USD Million)
  3. Asia-Pacific Continuous Wearable Devices Market, By Region, From 2020 to 2025 (USD Million)
  4. Asia-Pacific Continuous Wearable Devices Market, By Device Type, From 2020 to 2025 (USD Million)
  5. Asia-Pacific Sensors Market, By Region, From 2020 to 2025 (USD Million)
  6. Asia-Pacific Transmitters and Activators Market, By Region, From 2020 to 2025 (USD Million)
  7. Asia-Pacific Self-Monitoring Devices Market, By Region, From 2020 to 2025 (USD Million)
  8. Asia-Pacific Self-Monitoring Devices Market, By Device Type, From 2020 to 2025 (USD Million)
  9. Asia-Pacific Blood Glucose Meters Market, By Region, From 2020 to 2025 (USD Million)
  10. Asia-Pacific Blood Glucose Strips Market, By Region, From 2020 to 2025 (USD Million)
  11. Asia-Pacific Lancets Market, By Region, From 2020 to 2025 (USD Million)
  12. Asia-Pacific Haemoglobin A1C testing Kits Market, By Region, From 2020 to 2025 (USD Million)
  13. Asia-Pacific Glucose Monitoring Devices Market, By Application, From 2020 to 2025 (USD Million)
  14. Asia-Pacific Hospitals Market, By Region, From 2020 to 2025 (USD Million)
  15. Asia-Pacific Clinics and Diagnostic Centers Market, By Region, From 2020 to 2025 (USD Million)
  16. Asia-Pacific Home Setting Market, By Region, From 2020 to 2025 (USD Million)
  17. Asia-Pacific Ambulatory Settings Market, By Region, From 2020 to 2025 (USD Million)
  18. China Glucose Monitoring Devices Market, By Device Type, From 2020 to 2025 (USD Million)
  19. China Continuous Wearable Devices Market, By Device Type, From 2020 to 2025 (USD Million)
  20. China Self-Monitoring Devices Market, By Device Type, From 2020 to 2025 (USD Million)
  21. China Glucose Monitoring Devices Market, By Application, From 2020 to 2025 (USD Million)
  22. India Glucose Monitoring Devices Market, By Device Type, From 2020 to 2025 (USD Million)
  23. India Continuous Wearable Devices Market, By Device Type, From 2020 to 2025 (USD Million)
  24. India Self-Monitoring Devices Market, By Device Type, From 2020 to 2025 (USD Million)
  25. India Glucose Monitoring Devices Market, By Application, From 2020 to 2025 (USD Million)
  26. Japan Glucose Monitoring Devices Market, By Device Type, From 2020 to 2025 (USD Million)
  27. Japan Continuous Wearable Devices Market, By Device Type, From 2020 to 2025 (USD Million)
  28. Japan Self-Monitoring Devices Market, By Device Type, From 2020 to 2025 (USD Million)
  29. Japan Glucose Monitoring Devices Market, By Application, From 2020 to 2025 (USD Million)
  30. South Korea Glucose Monitoring Devices Market, By Device Type, From 2020 to 2025 (USD Million)
  31. South Korea Continuous Wearable Devices Market, By Device Type, From 2020 to 2025 (USD Million)
  32. South Korea Self-Monitoring Devices Market, By Device Type, From 2020 to 2025 (USD Million)
  33. South Korea Glucose Monitoring Devices Market, By Application, From 2020 to 2025 (USD Million)
  34. Australia Glucose Monitoring Devices Market, By Device Type, From 2020 to 2025 (USD Million)
  35. Australia Continuous Wearable Devices Market, By Device Type, From 2020 to 2025 (USD Million)
  36. Australia Self-Monitoring Devices Market, By Device Type, From 2020 to 2025 (USD Million)
  37. Australia Glucose Monitoring Devices Market, By Application, From 2020 to 2025 (USD Million)

Please wait. . . . Your request is being processed

Related Reports

LICENCE TYPE

$ 1234 3335

Clients
clients
clients
clients
clients
clients
clients
Click for Request Sample